News for Relay Therapeutics, Inc. (RLAY)

This stock is one of several featured in our latest research. For more small-cap opportunities with asymmetric return potential, read our free article: 10 Promising SmallCap Stocks Under $1 Billion Market Cap. We came across a bullish thesis on Arvinas, Inc. on Valueinvestorsclub.com by Ray Palmer. In this article, we will summarize the bulls’ thesis on ARVN. […]

PR NewswireVANCOUVER, BC, June 20, 2025 USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc.VANCOUVER, BC, June 20, 2025 /PRNewswire/

**media[652307]**

We came across a bullish thesis on Relay Therapeutics, Inc. (RLAY) on Steve Wagner’s Substack. In this article, we will summarize the bulls’ thesis on RLAY. Relay Therapeutics, Inc. (RLAY)’s share was trading at $3.23 as of 4th June. Relay Therapeutics is gaining momentum in oncology, thanks to promising data from its PI3Kα inhibitor RLY-2608, unveiled at […]

Updated interim data remain consistent, showing 10.3-month median PFS overall and 11.0-month median PFS in 2L patients with PI3Kα-mutated, HR+/HER2- metastatic

Relay Therapeutics (RLAY) has revealed promising interim data for their innovative drug, RLY-2608, an allosteric, pan-mutant, isoform-selective inhibitor target

CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. ( RLAY), a clinical-stage precision medicine company transforming the drug discove

Relay Therapeutics (RLAY) to participate in two major investor conferences in June 2025. Presentations will occur at the Jefferies and Goldman Sachs Glo

**media[640876]**

PR NewswireVANCOUVER, BC, May 27, 2025 Equity Insider News CommentaryIssued on behalf of Avant Technologies Inc.VANCOUVER, BC, May 27, 2025 /PRNewswire/ --

We recently published a list of 10 Best Low Priced Biotech Stocks to Buy Now. In this article, we are going to take a look at where Relay Therapeutics, Inc.

CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. ( RLAY), a clinical-stage precision medicine company transforming the drug disco

We recently published a list of the 11 Most Promising Penny Stocks According to Analysts. In this article, we are going to take a look at where Relay Therapeutics, Inc.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Wells Fargo has commenced coverage on Relay Therapeutics (RLAY) with an Equal Weight rating, setting a price target of $4. The financial institution has express

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Relay Therapeutics Inc.

We recently published a list of 10 Stocks Under $10 that Will Triple. In this article, we are going to take a look at where Relay Therapeutics, Inc. (NASDAQ:RLAY) stands against other stocks under $10 that will triple. As we delve into the discussion on stocks that will triple, we must shed light on the […]

**media[589978,589979]**

We recently published a list of Top 9 AI Ratings and News Updates on Wall Street’s Radar. In this article, we are going to take a look at where Relay Therapeutics Inc. (NASDAQ:RLAY) stands against other top AI ratings and news updates on Wall Street’s radar. Despite AI’s potential to transform our lives for the […]